Financing, Equity Capital Markets

XBiotech, Inc.

05/19
|
$40.0 Million
Piper Sandler served as sole bookrunner for XBiotech Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma